0001193125-22-072747.txt : 20220311 0001193125-22-072747.hdr.sgml : 20220311 20220311084601 ACCESSION NUMBER: 0001193125-22-072747 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220310 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 22731269 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 8-K 1 d309316d8k.htm 8-K 8-K
SPECTRUM PHARMACEUTICALS INC false 0000831547 0000831547 2022-03-10 2022-03-10

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 10, 2022

 

 

SPECTRUM PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-35006   93-0979187

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

11500 South Eastern Avenue   Suite 220   Henderson   Nevada   89052
(Address of principal executive offices)         (Zip Code)

Registrant’s telephone number, including area code: (702) 835-6300

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Common Stock, $0.001 par value   SPPI   The NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On March 10, 2022, Spectrum Pharmaceuticals, Inc. (the “Company”) received written notice (the “Notice”) from The NASDAQ Stock Market (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Select Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”), and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the Minimum Bid Price Requirement exists if the deficiency continues for a period of 30 consecutive business days.

The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Global Select Market. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial compliance period of 180 calendar days, or until September 6, 2022, to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the closing bid price of the Company’s common stock must meet or exceed $1.00 per share for a minimum of 10 consecutive business days prior to September 6, 2022. If at any time during this 180-day compliance period the closing bid price of the Company’s common stock meets these requirements, then Nasdaq will provide the Company with written confirmation of compliance and the matter will be closed.

If the Company does not regain compliance by September 6, 2022, the Company may be eligible for an additional 180-day compliance period if it applies to transfer the listing of its common stock to the Nasdaq Capital Market. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement. In addition, the Company would be required to provide written notice to Nasdaq of its intent to cure the minimum bid price deficiency during this second compliance period by effecting a reverse stock split, if necessary.

If the Company does not regain compliance within the allotted compliance period(s), including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s common stock will be subject to delisting. The Company would then be entitled to appeal the Nasdaq staff’s determination to a Nasdaq Listing Qualifications Panel and request a hearing.

The Company intends to monitor the closing bid price of the Company’s common stock and consider its available options to resolve the noncompliance with the Minimum Bid Price Requirement. No determination regarding the Company’s response has been made at this time. There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement or will otherwise be in compliance with other Nasdaq listing criteria.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    SPECTRUM PHARMACEUTICALS, INC.
Date: March 11, 2022     By:  

/s/ Keith M. McGahan

     

Keith M. McGahan

Executive Vice President, Chief Legal Officer and Secretary

 EX-101.SCH 2 sppi-20220310.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 sppi-20220310_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 sppi-20220310_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Document and Entity Information
Mar. 10, 2022
Cover [Abstract]  
Entity Registrant Name SPECTRUM PHARMACEUTICALS INC
Amendment Flag false
Entity Central Index Key 0000831547
Document Type 8-K
Document Period End Date Mar. 10, 2022
Entity Incorporation State Country Code DE
Entity File Number 001-35006
Entity Tax Identification Number 93-0979187
Entity Address, Address Line One 11500 South Eastern Avenue
Entity Address, Address Line Two Suite 220
Entity Address, City or Town Henderson
Entity Address, State or Province NV
Entity Address, Postal Zip Code 89052
City Area Code (702)
Local Phone Number 835-6300
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 par value
Trading Symbol SPPI
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 d309316d8k_htm.xml IDEA: XBRL DOCUMENT 0000831547 2022-03-10 2022-03-10 SPECTRUM PHARMACEUTICALS INC false 0000831547 8-K 2022-03-10 DE 001-35006 93-0979187 11500 South Eastern Avenue Suite 220 Henderson NV 89052 (702) 835-6300 false false false false Common Stock, $0.001 par value SPPI NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 1 118 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d309316d8k.htm sppi-20220310.xsd sppi-20220310_lab.xml sppi-20220310_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d309316d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d309316d8k.htm" ] }, "labelLink": { "local": [ "sppi-20220310_lab.xml" ] }, "presentationLink": { "local": [ "sppi-20220310_pre.xml" ] }, "schema": { "local": [ "sppi-20220310.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 118, "memberCustom": 0, "memberStandard": 0, "nsprefix": "sppi", "nsuri": "http://www.sppirx.com/20220310", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d309316d8k.htm", "contextRef": "duration_2022-03-10_to_2022-03-10", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d309316d8k.htm", "contextRef": "duration_2022-03-10_to_2022-03-10", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sppirx.com//20220310/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001193125-22-072747-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-072747-xbrl.zip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end